losartan has been researched along with Bladder Neck Obstruction in 3 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Excerpt | Relevance | Reference |
|---|---|---|
| " The renin-angiotensin system has been implicated in vascular and cardiac hypertrophy, but the involvement of angiotensin II (ANG II) as a trophic factor in the lower urinary tract has not been investigated." | 3.69 | Angiotensin II and bladder obstruction in the rat: influence on hypertrophic growth and contractility. ( Andersson, KE; Pandita, RK; Persson, K; Waldeck, K, 1996) |
| "• Treatment with losartan mediated an insignificant reduction in mean bladder weight (68." | 1.38 | Angiotensin II type 1 (AT-1) receptor inhibition partially prevents the urodynamic and detrusor changes associated with bladder outlet obstruction: a mouse model. ( Comiter, C; Phull, HS, 2012) |
| "Partial bladder neck obstruction was created in 23 rats by placing a 2-zero silk ligature around the vesicourethral junction." | 1.30 | The effect of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism on obstructed rat bladder. ( Cheng, EY; Decker, RS; Firlit, CF; Kaplan, WE; Lang, S; Lee, C; Palmer, LS, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Comiter, C | 1 |
| Phull, HS | 1 |
| Persson, K | 1 |
| Pandita, RK | 1 |
| Waldeck, K | 1 |
| Andersson, KE | 1 |
| Palmer, LS | 1 |
| Lee, C | 1 |
| Decker, RS | 1 |
| Lang, S | 1 |
| Kaplan, WE | 1 |
| Firlit, CF | 1 |
| Cheng, EY | 1 |
3 other studies available for losartan and Bladder Neck Obstruction
| Article | Year |
|---|---|
Angiotensin II type 1 (AT-1) receptor inhibition partially prevents the urodynamic and detrusor changes associated with bladder outlet obstruction: a mouse model.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Disease Models, Animal; Female; Ligation; Losartan | 2012 |
Angiotensin II and bladder obstruction in the rat: influence on hypertrophic growth and contractility.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Female; Hypertrophy; | 1996 |
The effect of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism on obstructed rat bladder.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compou | 1997 |